Little Evidence Supporting the Argument About Limiting the Patent Holder’s Right to Select the Licensing Level

Gregor Langus & Vilen Lipatov

In our new paper ‘Efficient level of SEPs licensing’, we examine the question whether a patent holder should be allowed to choose the level in the value chain at which to offer to license its standard essential patents (SEPs). SEPs are patents essential to practice industry standards, such as the fifth generation (5G) cellular standard. The question about the licensing level for SEPs has emerged in recent legal disputes, mainly in the automotive industry, where some have argued that a patent holder cannot decide to license its SEPs to manufacturers of connected cars, and must instead offer a license to any company that requests such a license, even if that company operates at a different level of the value chain.

We tackle the question of the optimal licensing level head-on, by analyzing how well the SEP holder’s private incentives in selecting the licensing level are aligned with the objective of maximizing the overall welfare, including benefiting consumers. If the SEP holder’s private incentives are well-aligned with this objective, then there is no reason to artificially restrict the patent holder’s right to select the level of the value chain at which to license its SEPs. We consider several determinants of the optimal licensing level—transaction costs, efficient differentiation in licensing terms, the optimal mix of implementation effort, entry incentives, and pricing distortions—and we find strong support for the conclusion that the SEP holder’s choice performs well in terms of maximization of the overall welfare, which therefore advises against restricting the SEP holders’ choice of the licensing level.

The analysis first focuses on transaction costs, which are costs that parties incur in executing a license. We find that the SEP holder will generally choose the licensing level that minimizes its private transaction costs, which often also minimizes the overall transaction costs. However, there is no similarly strong relation between an implementer’s preferred licensing level and minimal overall transaction costs. This is because the implementer can avoid transaction costs altogether by pushing licensing to a level at which the implementer is not active—irrespective of whether the licensees’ transaction costs at that level are lower or not. The analysis of transaction costs therefore favors leaving the choice of the licensing level to the SEP holder.

We also consider how the choice of licensing level affects the social welfare and consumers through factors other than transaction costs. The selection of the licensing level can expand the overall output (and welfare) if it induces a higher effort by market participants to implement the standards, higher market entry, and more efficient differentiation in licensing terms. Assuming the respect of the principle that “FRAND is FRAND”—that is, that an SEP holder is entitled to the same royalty per-unit of end product irrespective of the licensing level—it is easy to see why SEP holders have an interest in a large industry output. The only way for a SEP holder to increase its royalty revenue is to increase the overall industry output—that is, the use of the standard.

In contrast, for given margins, the implementers have an interest in boosting their private output, which is only loosely related to the total industry output. The incentive of the implementer to maximize its profits therefore tends to be separated further from the objective of the maximization of overall welfare as compared to the same private objective of the SEP holder. This analysis therefore also supports the proposition to leave to patent holders the right to select the level at which to license their SEPs.

Safeguarding Human Invention in the Age of Artificial Intelligence

By Alexander Kersten Introduction On October 30, President Joe Biden issued the Executive Order on the Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence. This comes at a time when artificial intelligence (AI)’s anticipated capabilities and applications are expected to have a tremendous impact on the future
Read More

Letter to Congress Correcting False Claims About Bayh-Dale Act and § 1498 on Drug Price Controls

On September 28th, 2023, a letter was sent to the Senate Health, Education, Labor and Pensions Committee, the Chair and Ranking Member of the House Ways and Means Committee, and to Secretary Becerra correcting false claims that the federal government can use the Bayh-Dole Act or § 1498 to impose
Read More

Dr. Kirti Gupta – Testimony: Innovating Ideas Around Standards and Intellectual Property

On September 20th, 2023, LeadershIP Executive Director Dr. Kirti Gupta testified for the ITA-NIST-USPTO Listening Session on Innovating Ideas Around Standards and Intellectual Property.    Transcript: Good afternoon. My name is Dr. Kirti Gupta and I am speaking on behalf of the Center for Strategic and International Studies (CSIS). Let
Read More